Full View

Atezolizumab with chemotherapy in first-line treatment for metastatic urothelial cancer: a cost–effectiveness analysis

PF Zhang, F Wen, QJ Wu, Q Li - Journal of Comparative …, 2022 - becarispublishing.com
Purpose: To evaluate the cost–effectiveness of atezolizumab plus chemotherapy as first-line
treatment for metastatic urothelial cancer (mUC). Materials & methods: A Markov model was …
相关文章

Atezolizumab with chemotherapy in first-line treatment for metastatic urothelial cancer: a cost-effectiveness analysis.

PF Zhang, F Wen, QJ Wu, Q Li - Journal of Comparative …, 2022 - europepmc.org
Purpose: To evaluate the cost-effectiveness of atezolizumab plus chemotherapy as first-line
treatment for metastatic urothelial cancer (mUC). Materials & methods: A Markov model was …

Atezolizumab with chemotherapy in first-line treatment for metastatic urothelial cancer: a cost-effectiveness analysis

PF Zhang, F Wen, QJ Wu, Q Li - Journal of comparative …, 2022 - pubmed.ncbi.nlm.nih.gov
Purpose: To evaluate the cost-effectiveness of atezolizumab plus chemotherapy as first-line
treatment for metastatic urothelial cancer (mUC). Materials & methods: A Markov model was …